Diflunisal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 912 publications
Qualitative and quantitative analysis of pharmaceutical content by terahertz spectroscopy and machine learning algorithms.
Journal: Analytical methods : advancing methods and applications
Published: July 27, 2026
Guidelines for the management of hereditary ATTR amyloidosis 2026.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: July 09, 2026
Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experience.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: June 03, 2026
Repurposing-inspired discovery of novel sagitta-shaped covalent TEAD inhibitors from NSAID diflunisal.
Journal: European journal of medicinal chemistry
Published: May 28, 2026
Disease-Modifying Therapies for Hereditary Transthyretin Amyloidosis with Polyneuropathy: Current Status and Future Perspectives.
Journal: Neurology and therapy
Published: May 23, 2026
Quantifying species-specific binding affinities of transthyretin aggregation inhibitors.
Journal: Biophysical reports
Published: April 10, 2026
Drug-Polymer Interactions and Molecular Miscibility in Amorphous Solid Dispersions: The Duality of Hydrogen Bond-Donor Groups.
Journal: Molecular pharmaceutics
Published: March 12, 2026
Multicenter cohort analysis of cardiac amyloidosis patients treated with heart transplant.
Journal: Revista espanola de cardiologia (English ed.)
Published: January 19, 2026
Pharmacological Interventions for Hereditary Transthyretin-Related Amyloidosis With Polyneuropathy: Systematic Review and Network Meta-Analysis.
Journal: European journal of neurology
Published: January 17, 2026
Exploring the Potential of Dendrimers in Skin Drug Delivery: Applications and Advances.
Journal: Current pharmaceutical design
Published: October 14, 2025
Repurposing Diflunisal as an Antivirulence Agent Against Staphylococcus aureus.
Journal: Infectious microbes & diseases
Published: August 14, 2025
Transcriptomic and bioinformatics analysis reveals the host response feature and potential treatment strategy of patients with dengue fever.
Journal: Frontiers in immunology
Published: August 09, 2025
Last Updated: 09/26/2026